Tackling Disparities | High-Fiber Diet | DES, Cancer Information Highlights, 01/05/2022

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI Black People Are More Likely to Die of Cancer—Here's How One Group Is Tackling That   A program called ACCURE is showing promise toward reducing disparities among Black and White people with breast and lung cancers. ACCURE involves system-wide changes at cancer centers to overcome barriers in patient care. A High-Fiber Diet May Improve Response to Immunotherapy   NCI researchers have found that a diet rich in fiber may help some people with melanoma respond to immunotherapy treatment by affecting bacteria in the gut. Read about the new findings from research in people and mice. DES Exposure and Cancer Risk We have updated this page about the drug DES (diethylstilbestrol), a synthetic form of estrogen. Learn how people are exposed to DES and about the health issues it may cause, including cancer. FDA Approvals Pembrolizumab Approved for Melanoma Following Surgery The Food and Drug Administration (FDA) has expanded the approved indications for pembrolizumab (Keytruda) to include the treatment of people aged 12 years or older with stage 2B, 2C, or 3 melanoma. Pembrolizumab may now be used to prevent melanoma from coming back after it has been removed by surgery. Rituximab Approved for Children with Non-Hodgkin Lymphoma (NHL) We've updated our drug summary on rituximab (Rituxan) with an expanded FDA approval. Rituximab is now approved to treat children 6 months and older with previously untreated diffuse large B-cell NHL or Burkitt lymphoma.   Also of Interest How to Find Cancer Resources You Can Trust Whether in print or online, cancer and other health information should come from a trusted, credible source. Learn how to find books, websites, and articles you can trust and how to use email and social media safely. COVID-19: What People with Cancer Should Know The COVID-19 situation in the United States continues to change, and so does advice from experts as they learn more. Learn the latest on how to protect yourself from COVID-19, and find advice on vaccine booster shots. Contact Us for Help Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892